The following is a special Covid-19 update from the optometrists and Dispensing Opticians Board (ODOB) FROM THE ODOB BOARD (27 Aug 2021)The Board would firstly like to thank all registrants in their
The New Zealand Medicines and Medical Devices Safety Authority (Medsafe) is asking eyecare professionals (ECPs) to report any ocular conditions that may be associated with a Covid-19 vaccination and has issued a new reporting form to simplify the process.
The Warehouse Group (TWG) has taken a stake in in Zoom Health, a health technology company and shareholder in Zoom Care, an online pharmacy delivering prescription medicine to patients. Door-to-door
A study has recommended extending virtual glaucoma clinic (VGC) eligibility criteria as a long-term adaptation for glaucoma care. The study team, led by Dr Eleni Nikita, Moorfields Eye Hospital, UK,
Nanoscope Therapeutics has dosed the first of 27 retinitis pigmentosa (RP) patients with its light activatable optogenetic monotherapy. The phase 2b US clinical trial of MCO-010 will deliver
Thousands of Kiwis with long-term health conditions remain Covid-19 vaccine hesitant while more than a quarter (29%) have not been offered a vaccine, a new survey has revealed. Addressing vaccine
Glaukos has announced a long-term real-world study of its iStent technologies demonstrated 30% intraocular pressure (IOP) reduction at 6-12 months and reduced glaucoma medication burden, with subjects
Australian researchers have developed a genetic glaucoma test from blood or saliva samples, which is 15 times more likely to flag high-risk individuals than existing genetic testing. The researchers
A new screening method using smartphone photos combined with an algorithm to detect anaemia may negate the need for an invasive blood test, reported US researchers. Anaemia, a low blood haemoglobin
Alcon is launching Total30, the company’s first-and-only monthly replacement, water-gradient lens for reusable contact lens wearers. Using the company’s proprietary water-gradient material first
The following is a special Covid-19 update from the New Zealand Association of Optometrists (NZAO) and the Optometrists and Dispensing Opticians Board (ODOB) FROM THE NZAO and the ODOB BOARD (19 Aug
Researchers at the Australian National University (ANU) have developed an ultra-thin nanocrystal material that converts infrared (IR) into visible light, paving the way for lightweight and cheap night-vision spectacles.